Search

Patricia Ann Duffy

Examiner (ID: 259, Phone: (571)272-0855 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1818, 1802, 1806, 1648, 1645
Total Applications
1732
Issued Applications
766
Pending Applications
286
Abandoned Applications
682

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 9759746 [patent_doc_number] => RE045170 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2014-09-30 [patent_title] => 'Streptococcus suis vaccines and diagnostic tests' [patent_app_type] => reissue [patent_app_number] => 14/015881 [patent_app_country] => US [patent_app_date] => 2013-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 61 [patent_figures_cnt] => 63 [patent_no_of_words] => 22438 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14015881 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/015881
Streptococcus suis vaccines and diagnostic tests Aug 29, 2013 Issued
Array ( [id] => 11843453 [patent_doc_number] => 09730993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-15 [patent_title] => 'Engineered anthrax lethal toxin for targeted delivery' [patent_app_type] => utility [patent_app_number] => 14/423408 [patent_app_country] => US [patent_app_date] => 2013-08-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23511 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 239 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14423408 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/423408
Engineered anthrax lethal toxin for targeted delivery Aug 21, 2013 Issued
Array ( [id] => 10474853 [patent_doc_number] => 20150359869 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-17 [patent_title] => 'METHODS AND COMPOSITIONS FOR PREVENTING A CONDITION' [patent_app_type] => utility [patent_app_number] => 14/422147 [patent_app_country] => US [patent_app_date] => 2013-08-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 21964 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14422147 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/422147
METHODS AND COMPOSITIONS FOR PREVENTING A CONDITION Aug 13, 2013 Abandoned
Array ( [id] => 9263153 [patent_doc_number] => 20130345082 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-26 [patent_title] => 'PEPTIDE NUCLEIC ACID PROBES FOR ANALYSIS OF CERTAIN STAPHYLOCOCCUS SPECIES' [patent_app_type] => utility [patent_app_number] => 13/955657 [patent_app_country] => US [patent_app_date] => 2013-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10377 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13955657 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/955657
PEPTIDE NUCLEIC ACID PROBES FOR ANALYSIS OF CERTAIN STAPHYLOCOCCUS SPECIES Jul 30, 2013 Abandoned
Array ( [id] => 9280301 [patent_doc_number] => 20140030269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'Staphylococcus aureus Specific Human Recombinant Polyclonal Antibodies and Uses Thereof' [patent_app_type] => utility [patent_app_number] => 13/951645 [patent_app_country] => US [patent_app_date] => 2013-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21545 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13951645 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/951645
Staphylococcus aureus Specific Human Recombinant Polyclonal Antibodies and Uses Thereof Jul 25, 2013 Abandoned
Array ( [id] => 10347511 [patent_doc_number] => 20150232517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-08-20 [patent_title] => 'MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO' [patent_app_type] => utility [patent_app_number] => 14/412722 [patent_app_country] => US [patent_app_date] => 2013-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 40890 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14412722 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/412722
MUTANT FRAGMENTS OF OspA AND METHODS AND USES RELATING THERETO Jul 7, 2013 Abandoned
Array ( [id] => 10267132 [patent_doc_number] => 20150152129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'Synthetic Oligosaccharides for P. Aeruginosa Vaccine' [patent_app_type] => utility [patent_app_number] => 14/414971 [patent_app_country] => US [patent_app_date] => 2013-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8569 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14414971 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/414971
Synthetic Oligosaccharides for P. Aeruginosa Vaccine Jul 2, 2013 Abandoned
Array ( [id] => 10443260 [patent_doc_number] => 20150328272 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-11-19 [patent_title] => 'Compositions for Improving the Development of Arteriosclerotic Vascular Diseases' [patent_app_type] => utility [patent_app_number] => 14/410566 [patent_app_country] => US [patent_app_date] => 2013-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12003 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14410566 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/410566
Compositions for Improving the Development of Arteriosclerotic Vascular Diseases Jun 16, 2013 Abandoned
Array ( [id] => 10869829 [patent_doc_number] => 08895021 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-11-25 [patent_title] => 'Sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof' [patent_app_type] => utility [patent_app_number] => 13/914423 [patent_app_country] => US [patent_app_date] => 2013-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23416 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13914423 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/914423
Sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof Jun 9, 2013 Issued
Array ( [id] => 9093786 [patent_doc_number] => 20130273097 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-17 [patent_title] => 'USE OF SACCHARIDES CROSS-REACTIVE WITH BACILLUS ANTHRACIS SPORE GLYCOPROTEIN AS A VACCINE AGAINST ANTHRAX' [patent_app_type] => utility [patent_app_number] => 13/909992 [patent_app_country] => US [patent_app_date] => 2013-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 13261 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13909992 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/909992
Use of saccharides cross-reactive with Bacillus anthracis spore glycoprotein as a vaccine against anthrax Jun 3, 2013 Issued
Array ( [id] => 9222475 [patent_doc_number] => 20140017251 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'BOTULINUM NEUROTOXIN A RECEPTOR AND THE USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/902323 [patent_app_country] => US [patent_app_date] => 2013-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13432 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13902323 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/902323
Botulinum neurotoxin a receptor and the use thereof May 23, 2013 Issued
Array ( [id] => 9977059 [patent_doc_number] => 09023366 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-05 [patent_title] => 'Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD)' [patent_app_type] => utility [patent_app_number] => 13/875958 [patent_app_country] => US [patent_app_date] => 2013-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 19552 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875958 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/875958
Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) May 1, 2013 Issued
Array ( [id] => 9916761 [patent_doc_number] => 20150071966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-03-12 [patent_title] => 'RODENT PLASMODIUM PARASITES AS PLATFORMS FOR A WHOLE-ORGANISM MALARIA VACCINE' [patent_app_type] => utility [patent_app_number] => 14/394964 [patent_app_country] => US [patent_app_date] => 2013-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5363 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14394964 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/394964
Rodent plasmodium parasites as platforms for a whole-organism malaria vaccine Apr 16, 2013 Issued
Array ( [id] => 8964269 [patent_doc_number] => 20130203871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'FUIDI HERD MANAGEMENT SCHEMA' [patent_app_type] => utility [patent_app_number] => 13/837941 [patent_app_country] => US [patent_app_date] => 2013-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10376 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13837941 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/837941
FUIDI HERD MANAGEMENT SCHEMA Mar 14, 2013 Abandoned
Array ( [id] => 8837958 [patent_doc_number] => 20130133586 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'FUIDI HERD MANAGEMENT SCHEMA' [patent_app_type] => utility [patent_app_number] => 13/751667 [patent_app_country] => US [patent_app_date] => 2013-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8588 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13751667 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/751667
FUIDI HERD MANAGEMENT SCHEMA Jan 27, 2013 Abandoned
Array ( [id] => 8951421 [patent_doc_number] => 20130197203 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-01 [patent_title] => 'Modified Polysaccharides for Conjugate Vaccines' [patent_app_type] => utility [patent_app_number] => 13/732861 [patent_app_country] => US [patent_app_date] => 2013-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17660 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13732861 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/732861
Modified Polysaccharides for Conjugate Vaccines Jan 1, 2013 Abandoned
Array ( [id] => 8989750 [patent_doc_number] => 20130217031 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-22 [patent_title] => 'GLYCEROGLYCOLIPID ANTIGEN OF MYCOPLASMA PNEUMONIAE' [patent_app_type] => utility [patent_app_number] => 13/729265 [patent_app_country] => US [patent_app_date] => 2012-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 11610 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13729265 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/729265
GLYCEROGLYCOLIPID ANTIGEN OF MYCOPLASMA PNEUMONIAE Dec 27, 2012 Abandoned
Array ( [id] => 10892560 [patent_doc_number] => 08916170 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-23 [patent_title] => 'Methods of producing antibodies against morphine-heroine' [patent_app_type] => utility [patent_app_number] => 13/709507 [patent_app_country] => US [patent_app_date] => 2012-12-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 19 [patent_no_of_words] => 19877 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13709507 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/709507
Methods of producing antibodies against morphine-heroine Dec 9, 2012 Issued
Array ( [id] => 9015537 [patent_doc_number] => 20130230502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'METHODS OF TREATING CANCER USING OPIOD RETARGETED ENDOPEPIDASES' [patent_app_type] => utility [patent_app_number] => 13/682398 [patent_app_country] => US [patent_app_date] => 2012-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 63277 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13682398 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/682398
METHODS OF TREATING CANCER USING OPIOD RETARGETED ENDOPEPIDASES Nov 19, 2012 Abandoned
Array ( [id] => 14639131 [patent_doc_number] => 10364298 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-30 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 14/358927 [patent_app_country] => US [patent_app_date] => 2012-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 12 [patent_no_of_words] => 14826 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358927 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/358927
None Nov 15, 2012 Issued
Menu